Literature DB >> 25903003

Liquid chromatography/tandem mass spectrometry method to determine boldenone in bovine liver tissues.

Rodrigo H M M Granja1, Alessandro G Salerno, Andreia C de Lima, Cynthia Montalvo, Karine V G Reche, Fabio M Giannotti, Amarylis C B A Wanschel.   

Abstract

Boldenone, an androgenic steroid, is forbidden for use in meat production in most countries worldwide. Residues of this drug in food present a potential risk to consumers. A sensitive LC/MS/MS method for analysis of 17β-boldenone using boldenone-d3 as an internal standard was developed. An enzymatic hydrolysis and extraction using ethyl acetate, methanol, and hexane were performed in the sample preparation. Parameters such as decision limit (CCα), detection capability (CCβ), precision, recovery, and ruggedness were evaluated according to the Brazilian Regulation 24/2009 (equivalent to European Union Decision 2002/657/EC) and International Organization for Standardization/International Electrotechnical Commission 17025:2005. CCα and CCβ were determined to be 0.17 and 0.29 μg/kg, respectively. Average recoveries from bovine liver samples fortified with 1, 1.5, and 2 μg/kg were around 100%. A complete statistical analysis was performed on the results obtained, including an estimation of the method uncertainty. The method is considered robust after being subjected to day-to-day analytical variations and has been used as a standard method in Brazil to report boldenone levels in bovine liver.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25903003     DOI: 10.5740/jaoacint.13-335

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  2 in total

1.  Ultrasonic diagnosis combined with targeted ultrasound contrast agent improves diagnostic sensitivity of ultrasonic for non-small cell lung cancer patients.

Authors:  Xiaohong Zhang; Can Xiao
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

2.  Contrast-enhanced computed tomography combined with Chitosan-Fe3O4 nanoparticles targeting fibroblast growth factor receptor and vascular endothelial growth factor receptor in the screening of early esophageal cancer.

Authors:  Juanjuan Gai; Zhenli Gao; Liqiang Song; Yongyun Xu; Weixin Liu; Chuanxin Zhao
Journal:  Exp Ther Med       Date:  2018-04-23       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.